Literature DB >> 2570701

Suppression of histamine-induced skin reactions by loratadine and cetirizine diHCl.

K Kontou-Fili1, G Paleologos, M Herakleous.   

Abstract

The skin reactivity to histamine was measured in 10 healthy and 10 atopic subjects after the ingestion of single doses of loratadine 10 mg, cetirizine diHCl 10 mg and placebo, in a double-blind cross-over randomized study. The anti-H1 effect of cetirizine diHCl proved to be significantly more rapid, more pronounced and longer lasting than that of loratadine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570701     DOI: 10.1007/BF00637746

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction.

Authors:  E N Charlesworth; A Kagey-Sobotka; P S Norman; L M Lichtenstein
Journal:  J Allergy Clin Immunol       Date:  1989-05       Impact factor: 10.793

2.  Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo.

Authors:  R Fadel; N Herpin-Richard; J P Rihoux; E Henocq
Journal:  Clin Allergy       Date:  1987-07

3.  Effect of an H1 blocker, chlorpheniramine, on inhalation tests with histamine and allergen in allergic asthma.

Authors:  V T Popa
Journal:  Chest       Date:  1980-09       Impact factor: 9.410

4.  Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine.

Authors:  A Barnett; L C Iorio; W Kreutner; S Tozzi; H S Ahn; A Gulbenkian
Journal:  Agents Actions       Date:  1984-06

5.  Comparative study of the peripheral and central effects of terfenadine and cetirizine 2 HCl.

Authors:  J P Rihoux; P Dupont
Journal:  Ann Allergy       Date:  1987-09

6.  Receptor effects of cetirizine.

Authors:  S H Snyder; A M Snowman
Journal:  Ann Allergy       Date:  1987-12

7.  Cetirizine inhibition of histamine-induced bronchospasm.

Authors:  D P Tashkin; A Brik; H Gong
Journal:  Ann Allergy       Date:  1987-12

8.  The effect of H1 and H2 blockade on cutaneous histamine response in man.

Authors:  R P Harvey; A L Schocket
Journal:  J Allergy Clin Immunol       Date:  1980-02       Impact factor: 10.793

9.  Antiallergic activity of loratadine, a non-sedating antihistamine.

Authors:  W Kreutner; R W Chapman; A Gulbenkian; M I Siegel
Journal:  Allergy       Date:  1987-01       Impact factor: 13.146

10.  Suppression of histamine-induced wheal response by loratadine (SCH 29851) over 28 days in man.

Authors:  I J Roman; N Kassem; R P Gural; J Herron
Journal:  Ann Allergy       Date:  1986-10
View more
  7 in total

Review 1.  Cetirizine. An updated review of its pharmacological properties and therapeutic efficacy.

Authors:  J P Rihoux; S Mariz
Journal:  Clin Rev Allergy       Date:  1993

Review 2.  Clinical pharmacology of new histamine H1 receptor antagonists.

Authors:  F E Simons; K J Simons
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

3.  Idiopathic histaminergic angioedema without wheals: a case series of 31 patients.

Authors:  C Faisant; I Boccon-Gibod; C Mansard; C Dumestre Perard; P Pralong; C Chatain; A Deroux; L Bouillet
Journal:  Clin Exp Immunol       Date:  2016-04-13       Impact factor: 4.330

Review 4.  Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria.

Authors:  D M Campoli-Richards; M M Buckley; A Fitton
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

5.  Inhibition of histamine-induced nasal obstruction by cetirizine in allergic rhinitis.

Authors:  G Braunstein; F Malaquin; I Fajac; M Melac; N Frossard
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

Review 6.  Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy.

Authors:  Christian Vestergaard; Mette Deleuran
Journal:  Ther Adv Chronic Dis       Date:  2015-11       Impact factor: 5.091

Review 7.  Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders.

Authors:  M Haria; A Fitton; D H Peters
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.